Quality of life (QoL) is used in the natural and social sciences as a relatively new category which deserves more attention in research. Quality of life related to health is a term commonly used when QoL on health. An increasing number of research studies that are based on an examination of the QoL. This paper analyzes the concept of the QoL, the possibilities of measuring the QoL, a special emphasis is placed on measuring QoL in dermatovenereology. Given that the skin disease are of particular significance for the patient, the said indices are dermatologically quality of life, especially the quality of life of patients dermatological (DLQI).

Cutaneus melanoma is the most malignant tumor of the skin. Melanoma arises from the malignant transformation of melanocytes at the dermal-epidermal junction or from the nevomelanocytes of atypical melanocytic nevi, that become invasive and metastasize after various time intervals. Dermoscopy is a noninvasive diagnostic technique in dermato- venereology that includes the inspection of the lesion with a handheld dermoscope. Dermoscopy enables the evaluation of the specific morphological structures of the skin that are not visible to the naked eye.therefore, it links clinical dermatology and dermatopathology. The major goal is to differentiate pigmented lesions into melanocytic and nonmelanocytic lesions, and make further differentiations within each group. Furthermore, it is essential to distinguish melanoma from other me- lanocytic and nonmelanocytic skin lesions, and to diagnose melanoma and amelanotic melanoma in their early stages. Der- moscopic follow up includes long-term and short-term monitoring, and is an essential diagnostic technique in the manage- ment of pigmented skin lesions.

In diabetics fungal skin infections are reported to be related to greatly disturbed metabolism. In order to get better insight into the association between diabetes mellitus and fungal skin infections, we started our study with the aim to assess the effect of metabolic regulation on the incidence of fungal skin infections is diabetics. The obtained results of our study show that in patient with metabolically poorly regulated primary disease i.e. diabetes the incidence of the fungal skin infections is highest (36.0%), its incidence is lower in patients with metabolically satisfactorily regulated diabetes (29.5%) and lowest in those with well regulated diabetes (18.8%), witch is statistically significant difference (p=0.045).

Oral isotretinoin is highly effective in treatment of patients with severe acne, but has been concerned with causing occasional depression. Clinicians should be alert to the high prevalence of depression among people with acne. Isotretinoin has many unwanted effects, among which possible unproven effects on mood have to be included. If depression or other mood change occurs, then isotretinoin treatment should be discontinued. If treatment is continued, psychiatric support should be obtained.

A chronic hyperglicemia with diabetes leads to damage, disfunction and physiology disorders in various organs and tissues so the skin changes are occuring frequently. They are serious and are early discovered. The importance of knowing the bacterial skin infection with diabetes patient is in the fact that sometimes they can be markers and be preceded of the manifestation of the diabetes during the years i.e. in the prevention of the complications even though the glucose tolerance is limited. Then, any increase of the glucose level should be considered patological. Acute and chronic bacterial skin infections can change the regulation of diabetes which may lead to worse metabolic regulation with diabetes patients. The bacterial skin infections belong to the infection group that according to the clinical experience more frequently appear
in diabetes. But a close connection with diabetes is not proved. This study aims to point out the bacterial skin infections with diabetes patients. The results of our study indicates that bacterial skin infections are more frequently represented with diabetes patients (11.0%) than with the persons without Diabetes mellitus (4.8%).